These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 26685215

  • 21. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis.
    Ma HT, Tsang YH, Marxer M, Poon RY.
    Mol Cell Biol; 2009 Dec; 29(24):6500-14. PubMed ID: 19822658
    [Abstract] [Full Text] [Related]

  • 22. Biochemical characterization of Cdk2-Speedy/Ringo A2.
    Cheng A, Gerry S, Kaldis P, Solomon MJ.
    BMC Biochem; 2005 Sep 28; 6():19. PubMed ID: 16191191
    [Abstract] [Full Text] [Related]

  • 23. Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements.
    Bendris N, Lemmers B, Blanchard JM, Arsic N.
    PLoS One; 2011 Sep 28; 6(7):e22879. PubMed ID: 21829545
    [Abstract] [Full Text] [Related]

  • 24. UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis.
    Chu J, Loughlin EA, Gaur NA, SenBanerjee S, Jacob V, Monson C, Kent B, Oranu A, Ding Y, Ukomadu C, Sadler KC.
    Mol Biol Cell; 2012 Jan 28; 23(1):59-70. PubMed ID: 22072796
    [Abstract] [Full Text] [Related]

  • 25. Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus.
    Moore NL, Weigel NL.
    Int J Biochem Cell Biol; 2011 Aug 28; 43(8):1157-67. PubMed ID: 21550420
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
    Guo B, Zhao Z, Wang Z, Li Q, Wang X, Wang W, Song T, Huang C.
    Cell Physiol Biochem; 2017 Aug 28; 42(4):1701-1711. PubMed ID: 28743112
    [Abstract] [Full Text] [Related]

  • 27. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway.
    Le XF, Bedrosian I, Mao W, Murray M, Lu Z, Keyomarsi K, Lee MH, Zhao J, Bast RC.
    Cell Cycle; 2006 Aug 28; 5(15):1654-61. PubMed ID: 16861913
    [Abstract] [Full Text] [Related]

  • 28. Cyclin-A-CDK2-mediated phosphorylation of CIZ1 blocks replisome formation and initiation of mammalian DNA replication.
    Copeland NA, Sercombe HE, Wilson RH, Coverley D.
    J Cell Sci; 2015 Apr 15; 128(8):1518-27. PubMed ID: 25736292
    [Abstract] [Full Text] [Related]

  • 29. Bruceantinol works as a CDK2/4/6 inhibitor to inhibit the growth of breast cancer cells.
    Sun L, Wang Y, Li J, Xu S, Xu S, Li J.
    Chem Biol Interact; 2024 May 25; 395():110999. PubMed ID: 38608999
    [Abstract] [Full Text] [Related]

  • 30. Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways.
    Sankaranarayanan R, Kumar DR, Altinoz MA, Bhat GJ.
    Int J Mol Sci; 2020 Nov 27; 21(23):. PubMed ID: 33260951
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effect of miR-340 over-expression on cell-cycle-related genes in triple-negative breast cancer cells.
    Mohammadi Yeganeh S, Vasei M, Tavakoli R, Kia V, Paryan M.
    Eur J Cancer Care (Engl); 2017 Nov 27; 26(6):. PubMed ID: 27229858
    [Abstract] [Full Text] [Related]

  • 35. Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma.
    Zhu Y, Ke KB, Xia ZK, Li HJ, Su R, Dong C, Zhou FM, Wang L, Chen R, Wu SG, Zhao H, Gu P, Leung KS, Wong MH, Lu G, Zhang JY, Jiang BH, Qiu JG, Shi XN, Lin MC.
    Mol Med; 2021 Feb 12; 27(1):15. PubMed ID: 33579185
    [Abstract] [Full Text] [Related]

  • 36. Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors.
    El-Naggar AM, El-Hashash MA, Elkaeed EB.
    Bioorg Chem; 2021 Mar 12; 108():104615. PubMed ID: 33484942
    [Abstract] [Full Text] [Related]

  • 37. Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
    Brown NR, Lowe ED, Petri E, Skamnaki V, Antrobus R, Johnson LN.
    Cell Cycle; 2007 Jun 01; 6(11):1350-9. PubMed ID: 17495531
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
    Tin AS, Sundar SN, Tran KQ, Park AH, Poindexter KM, Firestone GL.
    Anticancer Drugs; 2012 Apr 01; 23(4):370-9. PubMed ID: 22185819
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.